Accordingly, methylation of these genes does not seem to be very critical for BCP-ALL progression, and if so, this could be attributable to the combination of methylation and the loss of CDKN2B in the other allele [19,95]. The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.